Building Country Capacity for Immunization Delivery Costing Evidence Use


ThinkWell is leading a three year project focused on increasing the visibility, availability, understanding, and use of evidence on the cost of delivering vaccines. The project, supported by the Bill & Melinda Gates Foundation, aims to build country capacity around the generation and use of cost evidence to work towards sustainable and predictable financing for immunization. The countries included in this project are India, Indonesia, Tanzania, and Vietnam.


ThinkWell, along with partner John Snow Inc. (JSI), is supporting countries to generate cost information to address top domestic health and immunization financing agenda challenges to ensure program and policy relevance. ThinkWell is working with countries to improve interpretation and translation of cost information so that it is used in country decision-making processes, in addition to guiding fundraising and advocacy efforts and informing routine planning and budgeting processes. ThinkWell is facilitating a cross-country Immunization Costing Action Network (ICAN) to encourage knowledge sharing and co-production of effective strategies for generation and policy translation of cost evidence. ThinkWell is also conducting a systematic review of the delivery costs of immunization programs and developing a unit cost repository and cost benchmarks to ensure that immunization delivery cost data are globally accessible and easy to interpret.

Achievements in Year 1 (2016-2017)

Established and convened the Immunization Costing Action Network (ICAN) with country researchers, immunization managers, and Ministry of Health planners to collaborate on costing study designs, immunization costing methodological challenges, and challenges and best practices in interpreting and translating cost results for policy advocacy and planning.

Supported the development of costing study protocols and data collection instruments in Indonesia, Tanzania, and Vietnam.

Completed a systematic review of 500 resources, including published and grey literature, on the non-vaccine delivery costs of immunization programs in low- and middle-income countries.

Achievements and Status in Year 2 (2017-2018)

Launched the most comprehensive, current, and standardized global evidence on the cost of vaccine delivery (systematic review findings), including a standardized and richly annotated Immunization Delivery Cost Catalogue (IDCC) (Excel workbook and web tool) of the data extracted, summary report of findings including immunization delivery unit cost estimates for vaccine delivery through a variety of strategies and in a variety of contexts, and companion interpretive products (e.g., detailed methodology note and user guides).

Costing studies are underway in India, Indonesia, Tanzania and Vietnam.

Check out for more information.

Designed by BothAssociates   /  Photo Credits